Browse articles from EyeWorld.org related to IOLs. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
It was a successful year for the Journal of Cataract & Refractive Surgery (JCRS), the official journal of ASCRS and ESCRS, and JCRS Online Case Reports (JCRO), an online-only companion journal to JCRS. To celebrate this success, EyeWorld is featuring some of the most-viewed papers.
Nailing outcomes with presbyopia-correcting IOLs is important for many reasons—one of them being patient expectations, as they are paying out of pocket for an advanced-technology lens. But even when you’ve had an excellent surgery, postop complaints can trickle in, and the possible causes for the dissatisfaction are diverse.
➤ FDA approves treatment for macular edema following RVO ➤ New cyclosporine product receives approval for dry eye ➤ First human implant of 3D-bioprinted cornea ➤ Topline results from Phase 3 trial for Stargardt disease ➤ First patient treated with IDE glaucoma therapy ➤ Enrollment complete for Phase 2 trial for geographic atrophy treatment ➤ First patient implanted with investigational glaucoma shunt in trial ➤ Positive review of Phase 3 pivotal trial for AMD ➤ Company news ➤ ASCRS news and events
➤ Topline Phase 3 results for low-dose atropine drop ➤ 12-month data from prospective pilot study assessing aqueous shunt ➤ 5-year follow-up data supports safety, tolerability of investigational retinitis pigmentosa treatment. ➤ Randomization achieved in registrational trial for wet AMD therapy ➤ BLA submitted for thyroid eye disease treatment ➤ Company news ➤ ASCRS news and events
➤ New trifocal receives FDA approval ➤ Robotic system completes its first cataract surgery ➤ Interim results from first-in-human bimatoprost-IOL system ➤ Reproducible regenerative effects observed in preclinical glaucoma model ➤ Phase 3 program begins for intravitreal insert treating wet AMD, DME ➤ ASCRS news and events
EyeWorld reports on the BRiCS Summit, which took place October 3–5 in Chicago, Illinois. What the course really boils down to is increasing confidence in the premium IOL practice through education, resources, and networking connections, according to Vance Thompson, MD, chair, and William Wiley, MD, co-director.
While laser vision correction and IOL exchange remain the preferred methods for correcting residual refractive error, two ophthalmologists said there is still a place for piggyback IOLs. They spoke about when they would consider a piggyback IOL, their preferred lenses, and their thoughts on newer generation IOL options.
➤ Priority review granted to possible LHON treatment ➤ Update on drug in development for neuropathic corneal pain ➤ FDA approves generic bimatoprost ➤ Phase 1/2a clinical results for first-in-human retinal pigment epithelial stem cell therapy ➤ Adult dosing complete in trial for X-linked retinoschisis therapy ➤ Company news ➤ ASCRS news and events
In this YES Connect column, two surgeons described their techniques for how and when to successfully fixate a secondary lens when the capsule is either not present or not secure enough for traditional IOL implantation.